Tuatara Capital
Overview
Tuatara Capital is a sector-focused private equity firm dedicated to providing strategic, financial, and operational support to businesses in the legal cannabis industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Longplay USA, Inc. | Jan 2018 | Convertible Debt | Lead |
| Green Dot Labs | Sep 2017 | Series A | Lead |
| Hound Diagnostics | Sep 2021 | VC Round | Co-investor |
| Green Flower | Jun 2019 | Series A | Lead |
| Demetrix | Jul 2019 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Mark Zittman
Founding Partner
Al Foreman
Partner
Ivan Botev
Principal
Young Y.
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tuatara Capital based?
Tuatara Capital is headquartered in New York City, New York, United States.
When was Tuatara Capital founded?
Tuatara Capital was founded in 2014.
How many portfolio companies does Tuatara Capital have?
Tuatara Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Tuatara Capital's portfolio?
Portfolio companies visible on Caplight include Longplay USA, Inc., Green Dot Labs, Hound Diagnostics, Green Flower, Demetrix.
What was Tuatara Capital's most recent investment shown here?
Tuatara Capital's most recent investment in this portfolio sample was in Hound Diagnostics in 2021.
What sectors does Tuatara Capital focus on?
Tuatara Capital focuses on Consumer & Commerce, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, Enterprise Software, Consumer & Commerce, Healthcare & Life Sciences, Media, Entertainment & Gaming, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences.
What company stages does Tuatara Capital focus on?
Tuatara Capital typically invests at the MultiStage stage.
What is Tuatara Capital's AUM?
Tuatara Capital's assets under management are estimated between $132.1M and $400.0M.